IYH

iShares U.S. Healthcare ETF · PSE

Category Equity
Expense Ratio 0.4%
Listing Date Jun 16, 2000
Volume 449,407.0
Market Cap (AUM) $3,309.64M

Performance

-0.94%

1W

+2.33%

1M

-1.35%

3M

+11.71%

6M

+5.5%

YTD

+13.3%

1Y

Top Holdings

Name
Symbol
%Assets
Eli Lilly and CompanyLLY12.72%
UnitedHealth Group IncorporatedUNH8.25%
Johnson & JohnsonJNJ6.46%
Merck & Co., Inc.MRK5.83%
AbbVie, Inc.ABBV5.09%
Thermo Fisher Scientific Inc.TMO4.00%
Abbott LaboratoriesABT3.25%
Danaher CorporationDHR3.07%
Amgen Inc.AMGN2.96%
Pfizer Inc.PFE2.94%

Advanced Technical Analysis

Technical Analysis of IYH 2024-05-31

Overview:

In the last 5 trading days, IYH has shown a mixed performance based on various technical indicators. The stock price has fluctuated within a certain range, indicating indecision in the market. By analyzing trend, momentum, volatility, and volume indicators, we can gain insights into the possible future price movement of IYH.

Trend Anal...

See more ...

Recent News & Updates

2017-06-14 21:07
How Did Incytes Product Portfolio Look in 1Q17?(Marketrealist)
2017-06-11 21:07
Understanding Ionis Phamaceuticals Revenue Stream in 1Q17(Marketrealist)
2017-05-25 00:46
Rising Costs Are a Major Issue in the Healthcare Sector(Marketrealist)
2017-05-22 23:35
Merck & Co.s Segmental Performance in 1Q17(Marketrealist)
2017-05-18 22:36
Behind BMYs Cardiovascular Performance in 1Q17(Marketrealist)
2017-05-11 03:52
Biotech ETFs Sink After House Passage of Health-Care Bill(Wsj)
2017-05-10 19:37
Behind Allergans US General Medicines Segment in 1Q17(Marketrealist)
2017-05-05 00:07
A Prescription for Defense With Healthcare ETFs (IYH)(Investopedia)
2017-05-04 02:27
Health-care ETFs hold modest gain as House passes Obamacare replacement(Marketwatch)
2017-05-01 04:35
Analysts Ratings and Recommendations for Pfizer(Marketrealist)
2017-04-30 22:30
Mercks 1Q17 Estimates: Revenues Will Likely Decrease(Marketrealist)
2017-04-26 21:06
General Electrics Healthcare Revenue Rose in 1Q17(Marketrealist)
2017-04-23 22:06
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?(Yahoo Finance)
2017-04-23 19:36
Eli Lillys Cialis and Other Cardiovascular Products in 1Q17(Marketrealist)
2017-04-20 02:35
Will New Products Help Eli Lilly in 1Q17?(Marketrealist)
2017-04-20 01:46
Johnson & Johnsons 1Q17 Earnings Miss Revenue Estimates(Marketrealist)
2017-04-18 22:55
Lackluster J&J Q1 Pushes Healthcare ETFs Down(Yahoo Finance)
2017-04-17 00:17
5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings(Thestreet)
2017-04-07 03:05
How Bristol-Myers Squibb Stock Performed in 1Q17(Marketrealist)
2017-04-04 21:06
What Wall Street Analysts Recommend for Pfizer(Marketrealist)

Page 3 of 3

previousnext